Biohaven (BHVN) shares were up about 3% in recent Wednesday trading after RBC upgraded the biopharmaceutical firm's stock to outperform from sector perform and raised its price target to $22 from $9.
Trading volume stood at more than 2.18 million shares, compared with a daily average of over 4.23 million.
Price: 13.06, Change: +0.38, Percent Change: +2.96